| BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone J Moreaux, E Legouffe, E Jourdan, P Quittet, T Rème, C Lugagne, ... Blood 103 (8), 3148-3157, 2004 | 759 | 2004 |
| Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation K Tarte, J Gaillard, JJ Lataillade, L Fouillard, M Becker, H Mossafa, ... Blood, The Journal of the American Society of Hematology 115 (8), 1549-1553, 2010 | 510 | 2010 |
| Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer Y Kieffer, HR Hocine, G Gentric, F Pelon, C Bernard, B Bourachot, ... Cancer discovery 10 (9), 1330-1351, 2020 | 496 | 2020 |
| Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal M Krampera, J Galipeau, Y Shi, K Tarte, L Sensebe Cytotherapy 15 (9), 1054-1061, 2013 | 460 | 2013 |
| Risk of tumorigenicity in mesenchymal stromal cell–based therapies—bridging scientific observations and regulatory viewpoints L Barkholt, E Flory, V Jekerle, S Lucas-Samuel, P Ahnert, L Bisset, ... Cytotherapy 15 (7), 753-759, 2013 | 424 | 2013 |
| High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial D Rossille, M Gressier, D Damotte, D Maucort-Boulch, C Pangault, ... Leukemia 28 (12), 2367-2375, 2014 | 358 | 2014 |
| Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis P Amé-Thomas, H Maby-El Hajjami, C Monvoisin, R Jean, D Monnier, ... Blood 109 (2), 693-702, 2007 | 291 | 2007 |
| Survival and proliferation factors of normal and malignant plasma cells B Klein, K Tarte, M Jourdan, K Mathouk, J Moreaux, E Jourdan, ... International journal of hematology 78, 106-113, 2003 | 288 | 2003 |
| Good manufacturing practices production of mesenchymal stem/stromal cells L Sensebé, P Bourin, K Tarte Human gene therapy 22 (1), 19-26, 2011 | 275 | 2011 |
| Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation K Tarte, F Zhan, J De Vos, B Klein, J Shaughnessy Jr Blood 102 (2), 592-600, 2003 | 275 | 2003 |
| JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways … J De Vos, M Jourdan, K Tarte, C Jasmin, B Klein British journal of haematology 109 (4), 823-828, 2000 | 274 | 2000 |
| Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells M Boice, D Salloum, F Mourcin, V Sanghvi, R Amin, E Oricchio, M Jiang, ... Cell 167 (2), 405-418. e13, 2016 | 261 | 2016 |
| Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays J De Vos, T Thykjær, K Tarte, M Ensslen, P Raynaud, G Requirand, ... Oncogene 21 (44), 6848-6857, 2002 | 230 | 2002 |
| Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis F Uhel, I Azzaoui, M Grégoire, C Pangault, J Dulong, JM Tadié, A Gacouin, ... American journal of respiratory and critical care medicine 196 (3), 315-327, 2017 | 224 | 2017 |
| Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune … C Menard, L Pacelli, G Bassi, J Dulong, F Bifari, I Bezier, J Zanoncello, ... Stem cells and development 22 (12), 1789-1801, 2013 | 212 | 2013 |
| A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts S Huet, B Tesson, JP Jais, AL Feldman, L Magnano, E Thomas, ... The Lancet Oncology 19 (4), 549-561, 2018 | 209 | 2018 |
| Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts K Tarte, J De Vos, T Thykjaer, F Zhan, G Fiol, V Costes, T Reme, ... Blood, The Journal of the American Society of Hematology 100 (4), 1113-1122, 2002 | 198 | 2002 |
| Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells P Amé-Thomas, J Le Priol, H Yssel, G Caron, C Pangault, R Jean, ... Leukemia 26 (5), 1053-1063, 2012 | 197 | 2012 |
| Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays J De Vos, G Couderc, K Tarte, M Jourdan, G Requirand, MC Delteil, ... Blood, The Journal of the American Society of Hematology 98 (3), 771-780, 2001 | 185 | 2001 |
| Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes F Guilloton, G Caron, C Ménard, C Pangault, P Amé-Thomas, J Dulong, ... Blood, The Journal of the American Society of Hematology 119 (11), 2556-2567, 2012 | 177 | 2012 |
